July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Oculocerebrorenal Syndrome of Lowe: Characterizations of Ocular Presentation and Management
Author Affiliations & Notes
  • Xiaowan Ma
    Department of Ophthamology,Stanford university,PALO ALTO,CA,United States, Stanford Ophthalmology, Palo Alto, California, United States
  • ke ning
    Department of Ophthamology,Stanford university,PALO ALTO,CA,United States, Stanford Ophthalmology, Palo Alto, California, United States
  • Tia Kowal
    Department of Ophthamology,Stanford university,PALO ALTO,CA,United States, Stanford Ophthalmology, Palo Alto, California, United States
  • Yang Sun
    Department of Ophthamology,Stanford university,PALO ALTO,CA,United States, Stanford Ophthalmology, Palo Alto, California, United States
    Palo Alto VA medical center, California, United States
  • Footnotes
    Commercial Relationships   Xiaowan Ma, None; ke ning, None; Tia Kowal, None; Yang Sun, None
  • Footnotes
    Support  This work was supported by NIH/NEI K08-EY022058 (Y.S.), R01-EY025295 (Y.S.), VA merit CX001298 (Y.S.), Ziegler Foundation for the Blind (Y.S.), Showalter Foundation (Y.S.), Children’s Health Research Institute Award (Y.S.). Research for Prevention of Blindness Unrestricted grant (Stanford Ophthalmology), American Glaucoma Society (Y.S.), Lowe syndrome association (Y.S.), and Knights Templar Eye Foundation (Y.S.). P30 Vision Center grant to Stanford Ophthalmology department. Y.S. is a Laurie Kraus Lacob Faculty Scholar in Pediatric Translational Medicine.
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 1132. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Xiaowan Ma, ke ning, Tia Kowal, Yang Sun; Oculocerebrorenal Syndrome of Lowe: Characterizations of Ocular Presentation and Management. Invest. Ophthalmol. Vis. Sci. 2019;60(9):1132.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To describe the clinical manifestations of eye disease in a large cohort of Oculocerebrorenal syndrome of Lowe. Lowe syndrome is a rare X-linked recessive disease, caused by mutations in the OCRL gene. Affected patients develop congenital cataracts and glaucoma, mental and motor retardation and renal tubular dysfunction. Due to the rarity of disease, there is a paucity of clinical information for both clinicians and scientists for this condition. Therefore, the purpose of this study is to report the clinical characteristics and frequency of ocular conditions of Lowe syndrome.

Methods : Retrospective study of ophthalmologic presentations of 137 patients with clinically diagnoses of Lowe syndrome. We collected the medical history and ophthalmologic exams of affected patient, especially to evaluate the clinical manifestations of eyes such as cataracts, glaucoma, strabismus, nystagmus and corneal diseases.

Results : The mean current age of affected patients is 15.5 yrs (0.83~42yr).The average age of clinical diagnosis was 2.0 yrs (0.01~26yrs). Twenty-five percent of patients’ mothers have premature cataracts, with the average age of clinical diagnosis in maternal cataracts of 27.8 yrs. All patients with Lowe syndrome developed bilateral cataracts, and the mean diagnosed age was 0.1 yrs (0.01~2.0yrs). Other ophthalmological findings include glaucoma 54.7%, strabismus 35.0%, corneal scar 18.2%, and nystagmus 69.3%.

Conclusions : This study described the clinical features of ocular phenotypes of Lowe syndrome patients. Because ocular diseases in this condition are often observed first,this study provides critical information that may be useful for clinicians caring for these patients.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×